Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-01-15 00:00:00 ET · period of report 2026-01-15 · accession 0001468308-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-15 | 2026-01-15 | FENC | Andrade Robert | CFO | M - OptEx | $2.45 | +10.0K | 201.1K | +5% | +$24.5K |
| D | 2026-01-15 | 2026-01-15 | FENC | Andrade Robert | CFO | M - OptEx | $2.45 | -10.0K | 826.6K | -1% | -$24.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-01-15 | M | A | 10,000 | $2.45 | 201,100 | D | — | — | (F1) Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026. |
| 2 | Derivative | Stock Options | 2026-01-15 | M | D | 10,000 | $2.45 | 826,567 | D | $2.45 · 2016-07-05 to 2026-07-05 | 10,000 Options | (F1) Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026. |